Latest update on the Ro/SS-A autoantibody system

von Muhlen, 1995, Autoantibodies in the diagnosis of systemic rheumatic diseases, Semin Arthritis Rheum, 24, 323, 10.1016/S0049-0172(95)80004-2

Kobayashi, 2009, Neonatal lupus erythematosus in Japan: a review of the literature, Autoimmun Rev, 8, 462, 10.1016/j.autrev.2008.12.013

Fujimoto, 1997, Prevalence and clinical relevance of 52-kDa and 60-kDa Ro/SS-A autoantibodies in Japanese patients with systemic sclerosis, Ann Rheum Dis, 56, 667, 10.1136/ard.56.11.667

Anderson, 1962, Precipitating auto-antibodies in the connective tissue diseases, Ann Rheum Dis, 21, 360, 10.1136/ard.21.4.360

Clark, 1969, Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythematosus, J Immunol, 102, 117, 10.4049/jimmunol.102.1.117

Deutscher, 1988, Molecular analysis of the 60-kDa human Ro ribonucleoprotein, Proc Natl Acad Sci U S A, 85, 9479, 10.1073/pnas.85.24.9479

Ben Chetrit, 1989, Isolation and characterization of a cDNA clone encoding the 60-kD component of the human SS-A/Ro ribonucleoprotein autoantigen, J Clin Invest, 83, 1284, 10.1172/JCI114013

Chan, 1991, Molecular definition and sequence motifs of the 52-kD component of human SS-A/Ro autoantigen, J Clin Invest, 87, 68, 10.1172/JCI115003

Green, 1998, Binding of the 60-kDa Ro autoantigen to Y RNAs: evidence for recognition in the major groove of a conserved helix, RNA, 4, 750, 10.1017/S1355838298971667

Belisova, 2005, RNA chaperone activity of protein components of human Ro RNPs, RNA, 11, 1084, 10.1261/rna.7263905

Wolin, 2006, The Ro 60 kDa autoantigen comes into focus: interpreting epitope mapping experiments on the basis of structure, Autoimmun Rev, 5, 367, 10.1016/j.autrev.2005.10.004

McClain, 2005, Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry, Nat Med, 11, 85, 10.1038/nm1167

Doria, 2008, Infections as triggers and complications of systemic lupus erythematosus, Autoimmun Rev, 8, 24, 10.1016/j.autrev.2008.07.019

Poole, 2009, Aberrant Epstein–Barr viral infection in systemic lupus erythematosus, Autoimmun Rev, 8, 337, 10.1016/j.autrev.2008.12.008

Mahler, 2001, A population of autoantibodies against a centromere-associated protein A major epitope motif cross-reacts with related cryptic epitopes on other nuclear autoantigens and on the Epstein–Barr nuclear antigen 1, J Mol Med, 79, 722, 10.1007/s001090100258

Rhodes, 2002, The 52000 MW Ro/SS-A autoantigen in Sjogren's syndrome/systemic lupus erythematosus (Ro52) is an interferon-gamma inducible tripartite motif protein associated with membrane proximal structures, Immunology, 106, 246, 10.1046/j.1365-2567.2002.01417.x

Wada, 2006, Autoantigen Ro52 is an E3 ubiquitin ligase, Biochem Biophys Res Commun, 339, 415, 10.1016/j.bbrc.2005.11.029

Gomez-Martin, 2008, Ubiquitination system and autoimmunity: the bridge towards the modulation of the immune response, Autoimmun Rev, 7, 284, 10.1016/j.autrev.2007.11.026

Rutjes, 1997, Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy, Clin Exp Immunol, 109, 32, 10.1046/j.1365-2249.1997.4081308.x

Peene, 2002, Anti-Ro52 reactivity is an independent and additional serum marker in connective tissue disease, Ann Rheum Dis, 61, 929, 10.1136/ard.61.10.929

Rozman, 2000, Immunoserological aspects of idiopathic inflammatory muscle disease, Wien Klin Wochenschr, 112, 722

Brouwer, 2001, Autoantibody profiles in the sera of European patients with myositis, Ann Rheum Dis, 60, 116, 10.1136/ard.60.2.116

Koenig, 2007, Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes, Arthritis Res Ther, 9, R78, 10.1186/ar2276

Langguth, 2007, Specific testing for “isolated” anti-52 kDa SSA/Ro antibodies during standard anti-extractable nuclear antigen testing is of limited clinical value, J Clin Pathol, 60, 670, 10.1136/jcp.2006.040360

Tanaka, 2008, Anti-SS-A/Ro antibody determination by indirect immunofluorescence and comparison of different methods of anti-nuclear antibody screening: evaluation of the utility of HEp-2 cells transfected with the 60 kDa SS-A/Ro as a substrate, Mod Rheumatol, 18, 585, 10.1007/s10165-008-0100-x

Keech, 1994, Transfection and overexpression of the human 60-kDa Ro/SS-A autoantigen in HEp-2 cells, Clin Immunol Immunopathol, 73, 146, 10.1006/clin.1994.1181

Fritzler, 1995, Detection of autoantibodies to SS-A/Ro by indirect immunofluorescence using a transfected and overexpressed human 60 kD Ro autoantigen in HEp-2 cells, J Clin Lab Anal, 9, 218, 10.1002/jcla.1860090312

Hoffman, 2002, Detection of specific antinuclear reactivities in patients with negative anti-nuclear antibody immunofluorescence screening tests, Clin Chem, 48, 2171, 10.1093/clinchem/48.12.2171

Kidd, 2005, Detection and identification of significant ANAs in previously determined ANA negative samples, Clin Lab, 51, 517

Bossuyt, 2004, Detection of anti-SSA antibodies by indirect immunofluorescence, Clin Chem, 50, 2361, 10.1373/clinchem.2004.035964

Tan, 1988, Reference reagents for antinuclear antibodies, Arthritis Rheum, 31, 1331, 10.1002/art.1780311019

Smolen, 1997, Reference sera for antinuclear antibodies. II. Further definition of antibody specificities in international antinuclear antibody reference sera by immunofluorescence and western blotting, Arthritis Rheum, 40, 413, 10.1002/art.1780400304

Chan, 2007, AutoAbSC.Org — Autoantibody Standardization Committee in 2006, Autoimmun Rev, 6, 577, 10.1016/j.autrev.2007.05.001

Tan, 1988, Antinuclear antibodies: diagnostic markers and clues to the basis of systemic autoimmunity, Pediatr Infect Dis J, 7, S3, 10.1097/00006454-198805001-00002

Tan, 1982, Reference sera for antinuclear antibodies. I. Antibodies to native DNA, Sm, nuclear RNP, and SS-B/La, Arthritis Rheum, 25, 1003, 10.1002/art.1780250814